Aktis Oncology annual revenue
2022
2023
2024
2025
Aktis Oncology Revenue Growth & History (AKTS)
Aktis Oncology reported $6.5M in revenue for fiscal 2025, an increase of 336.92% from the previous fiscal year.
View full Aktis Oncology company overviewAktis Oncology annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $6.5M | $5.0M | +336.92% |
| 2024 | 2024-12-31 | $1.5M | $1.5M | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | — | — |
Aktis Oncology quarterly revenue
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.4M | $1.8M | +111.37% |
| Q1 2026 | 2026-03-31 | $3.2M | $1.8M | +123.01% |
| Q4 2025 | 2025-12-31 | $1.9M | $937,000 | +100.43% |
| Q3 2025 | 2025-09-30 | $1.6M | — | — |
| Q2 2025 | 2025-06-30 | $1.6M | — | — |
| Q1 2025 | 2025-03-31 | $1.4M | — | — |
| Q4 2024 | 2024-12-31 | $933,000 | — | — |
Aktis Oncology revenue growth trends
Aktis Oncology's latest reported quarter, Q2 2026, generated $3.4M in revenue, an increase of 111.37% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Aktis Oncology source filings ↗